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HIV entry. HIV requires a chemokine coreceptor, either
CCR5 or CXCR4, in addition to CD4 to enter target cells.
A recently proposed model, based on apparent structural
homology between the V3 region of the envelope glyco-
protein and chemokine beta-hairpin loops, suggests that
the V3 region may direct coreceptor choice through struc-
tural mimicry of the chemokines that bind to either core-
ceptor. Some of our recent research based on available
chemokine structure-activity data has produced evidence
that challenges this model.
HIV entry inhibition. The native ligands of HIV corecep-
tors prevent viral entry via a combination of steric block-
ade and removal of receptors from the cell surface
(receptor sequestration). Our work on synthetic and semi-
synthetic chemokine analogues has led to the discovery of
potent HIV entry inhibitors such as PSC-RANTES, which
owe their activity to a greatly enhanced capacity to seques-
ter CCR5. PSC-RANTES has shown promise as a microbi-
cide candidate, but as a totally synthetic protein it is likely
to be too expensive for use in the developing world. We
are now focused on discovering similarly potent mole-
cules that are either partly or wholly accessible by biosyn-
thesis and thus much cheaper to produce.
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